New trends in hyperosmolar therapy?

Current Opinion in Critical Care

Volumn 19, Issue 2, 2013, Pages 77-82

  Diringer, Michael N ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cerebral edema; hypertonic saline; intracranial hypertension; mannitol

Indexed keywords

MANNITOL; RINGER LACTATE SOLUTION; SODIUM CHLORIDE;

ANTIHYPERTENSIVE THERAPY; BLOOD BRAIN BARRIER; CONTINUOUS INFUSION; HEAD INJURY; HUMAN; HYPEROSMOLAR THERAPY; HYPEROSMOLARITY; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; OSMOLALITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREND STUDY;

BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; CRANIOCEREBRAL TRAUMA; CRITICAL CARE; DIURETICS, OSMOTIC; FEMALE; HUMANS; INTRACRANIAL HYPERTENSION; MALE; MANNITOL; OSMOLAR CONCENTRATION; PRACTICE GUIDELINES AS TOPIC; SALINE SOLUTION, HYPERTONIC; TREATMENT OUTCOME;

EID: 84874764849     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e32835eba30     Document Type: Review

References (41)

1. Weed LH, McKibbens PR. Experimental alterations of brain bulk. Am J Physiol 1919; 48:512-530.
2. Fay T. The treatment of acute and chronic cases of cerebral trauma by methods of dehydration. Ann Surg 1935; 101:76-132.
3. Shenkin HA, Goluboff B, Haft H. The use of mannitol for the reduction of intracranial pressure in intracranial surgery. J Neurosurg 1962; 19:897-901.
4. Wise BL, Chater N. The value of hypertonic mannitol solution in decreasing brain mass and lowering cerebro-spinal-fluid pressure. J Neurosurg 1962; 19:1038-1043.
5. Marko NF. Hypertonic saline, not mannitol, should be considered gold-standard medical therapy for intracranial hypertension. Crit Care 2012; 16:113.
6. Grape S, Ravussin P. Pro: osmotherapy for the treatment of acute intracranial hypertension. J Neurosurg Anesthesiol 2012; 24:402-406.
7. Grande PO, Romner B. Osmotherapy in brain edema. a questionable therapy. J Neurosurg Anesthesiol 2012; 24:407-412.
8. Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. II. Hyperosmolar therapy. J Neurotrauma 2007; 24 (Suppl 1):S14-S20.
9. Adams HP Jr, Brott TG, Crowell RM, et al. Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation 1994; 90:1588-1601. (Pubitemid 24284492)
10. Morgenstern LB, Hemphill JC 3rd, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage. A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010; 41:2108-2129.
11. Olson JE, Banks M, Dimlich RV, Evers J. Blood-brain barrier water permeability and brain osmolyte content during edema development. Acad Emerg Med 1997; 4:662-673. (Pubitemid 27300407)
12. Rosenberg GA, Kyner WT, Fenstermacher JD, Patlak CS. Effect of vasopressin on ependymal and capillary permeability to tritiated water in cat. Am J Physiol 1986; 251:F485-489.
13. Badaut J, Ashwal S, Obenaus A. Aquaporins in cerebrovascular disease. a target for treatment of brain edema? Cerebrovasc Dis 2011; 31:521-531.
14. Zelenina M. Regulation of brain aquaporins. Neurochem Int 2010; 57:468-488.
15. Matsuoka Y, Hossmann KA. Brain tissue osmolality after middle cerebral artery occlusion in cats. Exp Neurol 1982; 77:599-611. (Pubitemid 12011173)
16. Bowers SA, Marshall LF. Outcome in 200 consecutive cases of severe head injury treated in San Diego County. A prospective analysis. Neurosurgery 1980; 6:237-242. (Pubitemid 10133797)
17. Keyrouz SG, Dhar R, Diringer MN. Variation in osmotic response to sustained mannitol administration. Neurocrit Care 2008; 9:204-209.
18. Adrogue HJ, Madias NE. Hypernatremia. N Engl J Med 2000; 342:1493-1499. (Pubitemid 30318274)
19. Gullans SR, Verbalis JG. Control of brain volume during hyperosmolar and hypoosmolar conditions. Annu Rev Med 1993; 44:289-301. (Pubitemid 23117868)
20. McManus ML, Churchwell KB, Strange K. Regulation of cell volume in health and disease. N Engl J Med 1995; 333:1260-1266.
21. Go KG. The fluid environment of the central nervous system. In Cerebral pathophysiology. Elsevier; 1991.
22. Burke AM, Quest DO, Chien S, Cerri C. The effects of mannitol on blood viscosity. J Neurosurg 1981; 55:550-553. (Pubitemid 12227586)
23. Hijiya N, Horiuchi K, Asakura T. Morphology of sickle cells produced in solutions of varying osmolarities. J Lab Clin Med 1991; 117:60-66.
24. Worthley LI, Cooper DJ, Jones N. Treatment of resistant intracranial hypertension with hypertonic saline. Report of two cases. J Neurosurg 1988; 68:478-481. (Pubitemid 18067652)
25. Prough DS, Johnson JC, Stump DA, et al. Effects of hypertonic saline versus lactated Ringer's solution on cerebral oxygen transport during resuscitation from hemorrhagic shock. J Neurosurg 1986; 64:627-632. (Pubitemid 16039164)
26. Hays AN, Lazaridis C, Neyens R, et al. Osmotherapy: use among neurointensivists. Neurocrit Care 2011; 14:222-228.
27. Sakellaridis N, Pavlou E, Karatzas S, et al. Comparison of mannitol and hypertonic saline in the treatment of severe brain injuries. J Neurosurg 2011; 114:545-548.
28. Kamel H, Navi BB, Nakagawa K, et al. Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials. Crit Care Med 2011; 39:554-559.
29. Mortazavi MM, Romeo AK, Deep A, et al. Hypertonic saline for treating raised intracranial pressure: literature review with meta-analysis. J Neurosurg 2012; 116:210-221.
30. Duhaime AC. Traumatic brain injuries. J Neurosurg 2011; 114:543; discussion 544.
31. Defillo A. Mannitol versus saline. J Neurosurg 2012; 116:256-257; author reply 257.
32. Nakagawa K, Chang CW, Koenig MA, et al. Treatment of refractory intracranial hypertension with 23.4% saline in children with severe traumatic brain injury. J Clin Anesth 2012; 24:318-323.
33. Luu JL, Wendtland CL, Gross MF, et al. Three-percentage saline administration during pediatric critical care transport. Pediatr Emerg Care 2011; 27:1113-1117.
34. Bennett TD, Statler KD, Korgenski EK, Bratton SL. Osmolar therapy in pediatric traumatic brain injury. Crit Care Med 2012; 40:208-215.
35. Becker DP, Vries J. The alleviation of increased intracranial pressure by the chronic administration of osmotic agents. In Brock M, Dietz H, editors. Intracranial pressure. Springer; 1972. pp. 309-315.
36. Simma B, Burger R, Falk M, et al. A prospective, randomized, and controlled study of fluid management in children with severe head injury: lactated Ringer's solution versus hypertonic saline. Crit Care Med 1998; 26:1265-1270. (Pubitemid 28334983)
37. Froelich M, Ni Q, Wess C, et al. Continuous hypertonic saline therapy and the occurrence of complications in neurocritically ill patients. Crit Care Med 2009; 37:1433-1441.
38. Hauer EM, Stark D, Staykov D, et al. Early continuous hypertonic saline infusion in patients with severe cerebrovascular disease. Crit Care Med 2011; 39:1766-1772.
39. Wagner I, Hauer EM, Staykov D, et al. Effects of continuous hypertonic saline infusion on perihemorrhagic edema evolution. Stroke 2011; 42:1540-1545.
40. Roquilly A, Mahe PJ, Latte DD, et al. Continuous controlled-infusion of hypertonic saline solution in traumatic brain-injured patients: a 9-year retrospective study. Crit Care 2011; 15:R260.
41. Chestnut RM. Special session: results of the ICP monitoring randomized trial. In 10th Annual Neurocritical Care Society Meeting. Denver, Colorado; 2012.